Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18-59
SponsorUniversitas Padjadjaran

About this trial

In operating procedure with general anesthesia muscle relaxant is usually used to increase success rate of the operation and to give better outcome. The use of reversal drugs aims to reduce the risk of post-operative complications due to muscle relaxants. Neostigmine is commonly used as a reversal drug, but its indirect mechanism of action results in a long and unpredictable recovery time. Sugammadex directly bind and inactivate rocuronium, in which resulting in a faster and predictable recovery time. However, the high price limits the use of sugammadex.

This study aims to compare the effect of half dose sugammadex and neostigmine against the moderate neuromuscular blockade of rocuronium.

The main questions it aims to answer are:

Does half dose sugammadex gives faster recovery time? Researchers will compare sugammadex to neostigmine to see if sugammadex gives faster recovery time.

Participants will:

Be given sugammadex or neostigmine as a reversal drug after the operation done

Eligibility criteria

Qualifiers

Patients who underwent laparoscopic cholecystectomy under general anesthesia

Using muscle relaxant rocuronium

Aged 18-59 years

American Society of Anesthesiologists (ASA) physical status classification of 1 or 2.

Disqualifiers

History of drug allergies to the agents used

Renal dysfunction

Musculoskeletal disorders

Central nervous system disorders

Trial design

Treatments tested in this trial

  • Sugammadex 1 mg/kg
  • Neostigmine + Atropine

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators